Author: Dr. Nikhilesh R. Sekhar, MD, FACS, FASMBS
Introduction
Obesity is often framed as a cosmetic concern, but its true impact runs far deeper than appearance. Research now makes it clear: excess body fat directly fuels the growth of certain cancers. A groundbreaking study presented at ENDO 2025 by researchers at Jersey Shore University Medical Center and Hackensack Meridian Health reveals that obesity-related cancer deaths have surged dramatically across the United States over the past two decades.
Between 1999 and 2020, more than 33,000 deaths from obesity-associated cancers were analyzed. Deaths linked to obesity-related cancers more than tripled, rising from 3.73 million to 13.52 million, with the steepest climb between 2018 and 2020.
Study Findings
- Over 33,000 deaths from obesity-associated cancers were tracked across a 21-year period.
- The burden was highest among older adults, women, and racial minorities.
- Regional differences were clear: the Midwest had the highest obesity-related cancer death rates, while the Northeast had the lowest.
- States with the highest rates included Vermont, Minnesota, and Oklahoma.
- The lowest rates were seen in Utah, Alabama, and Virginia.
- Nearly 40% of Americans currently live with obesity, placing them at higher risk for cancer.
How Obesity Fuels Cancer
Several biological mechanisms explain the connection:
- Inflammation and ‘angry’ fat cells: Excess fat tissue is biologically active. It releases cytokines—chemical signals that cause chronic inflammation and disrupt the body’s normal regulation. This inflammatory environment supports cancer growth.
- Hormonal disruption: Obesity alters hormone levels, including insulin and estrogen, both of which are known to stimulate cancer development.
- Immune system changes: Chronic inflammation weakens the immune system’s ability to detect and eliminate abnormal cells early.
Because of these effects, obesity-related cancers tend to be more aggressive and harder to treat.
Populations Most at Risk
- Older adults: longer lifetime exposure to obesity increases the likelihood of cancer.
- Women: obesity has strong links to breast, ovarian, and uterine cancers.
- Racial minorities: disparities in access to healthy foods, exercise opportunities, and preventive healthcare contribute to higher risk.
- Regional groups: diet patterns, healthcare access, and obesity prevalence vary significantly across the country.
Obesity-related cancers are now appearing in younger adults, not just older populations.
Clinical Implications
Obesity is linked to at least 13 cancer types, including:
- Breast
- Colorectal
- Endometrial (uterine)
- Esophageal
- Kidney
- Liver
- Pancreatic
- Ovarian
Together, these cancers represent 40% of all U.S. cancer diagnoses annually. Rising obesity rates mean more patients will face aggressive cancers that are difficult and costly to treat.
Prevention and Patient Education
Obesity is a modifiable risk factor. Preventive measures can make a major difference:
- Weight loss reduces inflammation: even modest reductions in body weight lower cancer-promoting cytokines.
- GLP-1 medications: originally designed for diabetes, these medications aid weight loss and are now being studied for cancer risk reduction.
- Bariatric surgery: effective for long-term weight loss, with proven metabolic benefits that reduce systemic inflammation.
- Lifestyle changes: a healthy diet, regular physical activity, limiting alcohol, and avoiding tobacco all play protective roles.
Preventing obesity is far more effective than trying to treat cancer once it develops.
Bariatric Surgery and Cancer Risk
For patients with severe obesity, bariatric surgery is a powerful option that lowers cancer risk while improving overall health.
- Direct benefits: sustained weight loss, correction of hormonal imbalance, and decreased inflammation.
- Indirect benefits: better quality of life, reduced risk of diabetes and heart disease, and lower long-term healthcare costs.
Long-term studies confirm that bariatric surgery not only extends life expectancy but also decreases the risk of developing obesity-related cancers.
At New York Bariatric Group (NYBG), patients are counseled that surgery is not a cosmetic fix but an evidence-based medical intervention with life-saving potential.
Addressing Common Misconceptions
- “Cancer only affects older adults.” Obesity-related cancers are increasingly diagnosed in younger adults.
- “No family history means I’m safe.” Genetics play a role, but obesity itself is an independent risk factor.
- “Surgery is too extreme.” For many patients, bariatric surgery is safer than the long-term risks of untreated obesity.
Reframing obesity as a serious medical condition—rather than a cosmetic issue—helps patients overcome stigma and consider treatment.
Screening and Patient Selection
Healthcare providers should:
- Offer earlier cancer screening for patients with obesity, especially those with additional risk factors.
- Personalize recommendations based on weight history, family history, and comorbid conditions.
- Encourage timely action: whether through lifestyle changes, medications, or bariatric surgery, reducing excess weight lowers future cancer risk.
Conclusion
The dramatic rise in obesity-related cancer deaths—from 3.73 million to 13.52 million in just two decades—underscores the urgency of addressing obesity as a medical condition.
Weight loss through lifestyle changes, medications, and surgery is not just about appearance or numbers on a scale. It directly reduces cancer risk, saves lives, and improves long-term health.
At NYBG, patients are supported with evidence-based treatments, preventive education, and long-term follow-up. The goal is clear: empower individuals to take control of their health and reduce their risk of cancer.
Reference
Cancer deaths hit ‘alarming’ surge due to common health condition, experts say (ENDO 2025 presentation, Jersey Shore University Medical Center and Hackensack Meridian Health).
Back to Blog
